Upon T cell activation, ICOS expression is observed, and the interaction of ICOS with its ligand, ICOSL, exhibits co-stimulatory properties fostering anti-tumor responses in Th1, CTL, and Tfh cells (14). Here, ICOS is linked to neoplasm.